Sergio Cifuentes Canaval, Medical Oncologist, ASCO International Development and Education Award (IDEA) Recipient – 2025 at Conquer Cancer, the ASCO Foundation, shared a post on X:
“New arrival of ENCORA + CETUXIMAB in Colombia.
A step forward in expanding treatment options for patients with BRAF V600E-mutated mCRC. Looking forward to its approval in 1L soon.”
More posts on OncoDaily.